News

India's PLI scheme transforms pharma industry from policy to practice: Vikram Aditya Sehgal: Nandita Vijayasimha, Bengaluru Thursday, August 7, 2025, 08:00 Hrs [IST] India's produ ...
The Indian pharmaceutical industry has been excluded from the United States' latest round of tariff hikes, with Washington ...
The United States has imposed a 25% tariff on Indian goods. This is due to India's continued purchase of Russian oil. The new ...
Pharmexcil Chairman warns US tariffs on Indian pharma will impact global industry, affecting affordable healthcare and ...
Indian pharma companies will need to change tack and find newer markets should the Trump administration impose a reciprocal ...
The US has imposed a steep 25 per cent tariff on Indian goods, targeting key export sectors like textiles, diamonds, and auto ...
U.S. President Donald Trump said that tariffs on imported pharmaceuticals can be as much as 250 percent after initially ...
POTENTIAL Indian investors have indicated their interest in pursuing pharmaceutical and infrastructure ventures in the ...
The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...
No impact going forward on the Indian pharma industry due to US tariff policy: IDMA: Shardul Nautiyal, Mumbai Saturday, August 2, 2025, 08:00 Hrs [IST] US President Donald Trumps ...
These tariffs would drastically undermine the price advantage Indian drug makers currently enjoy in the US, especially in ...
Out of the 20 stocks that make up the Nifty Pharma index, 18 were trading in the red, reflecting a broad-based sell-off. The ...